Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Oxytocin
Drug ID BADD_D01652
Description Sir Henry H. Dale first identified oxytocin and its uterine contractile properties in 1906.[A229008,A228593,A229108] Like all other neurohypophysial hormones, oxytocin is composed of nine amino acids with a disulfide bridge between the Cys 1 and 6 residues.[A229008,A228593] In the mid-1950s, synthetic oxytocin was successfully synthesized by a biochemist named Vincent du Vigneaud; he was later recognized with a Nobel prize for his work.[A229108] Oxytocin continues to be an important tool in modern obstetrics to induce labor when indicated and to manage postpartum hemorrhage.[A229108,A229113] It is estimated that labor induction with oxytocin is used in almost 10% of deliveries globally.[A228593] It should be noted that there are risks associated with oxytocin intervention during childbirth. Oxytocin should be used judiciously only when necessary and by experienced healthcare practitioners.[A229113] Although most commonly linked to labor and delivery, oxytocin actually has broad peripheral and central effects.[A229008] It plays an important role in pair bonding, social cognition and functioning, and even fear conditioning.[A229013] Oxytocin also serves a role in metabolic homeostasis and cardiovascular regulation.[A228593,A229098]
Indications and Usage Used for labor induction, augmentation of labor, postpartum abbreviation of third stage of labor, postpartum control of uterine bleeding, termination of pregnancy and for the evaluation of fetal respiratory capability. Oxytocin cannot be used for elective induction of labor, there must be a clear medical requirement.
Marketing Status Prescription; Discontinued
ATC Code H01BB02
DrugBank ID DB00107
KEGG ID D00089
MeSH ID D010121
PubChem ID 439302
TTD Drug ID D0M3FJ
NDC Product Code 76617-011; 46600-0001; 63323-012; 41701-002; 0641-6115; 38779-2492; 75882-213; 42023-130; 55154-9584; 49452-4956; 0143-9742; 63275-9881; 0641-6114; 0143-9743; 51552-0631; 51927-2843; 64189-1202; 70155-001; 62991-3133; 60870-0438; 42023-116
Synonyms Oxytocin | Ocytocin | Syntocinon | Pitocin
Chemical Information
Molecular Formula C43H66N12O12S2
CAS Registry Number 50-56-6
SMILES CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3C CCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Alcohol intoleranceOxytocin-neurophysin 1P35454Not Available2884803; 3593487
Erection and ejaculation conditions and disordersCorticoliberinP01143Not Available3792449; 1358647; 3032653
YawningCorticotropin-releasing factor receptor 1P35353Not Available3792449; 1358647; 3032653
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acute pulmonary oedema22.01.03.005; 02.05.02.004--Not Available
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction10.01.07.003; 24.06.03.007--Not Available
Apgar score low13.15.01.012--Not Available
Arrhythmia02.03.02.001--Not Available
Asphyxia22.02.02.001; 12.01.08.011--Not Available
Bradycardia02.03.02.002--Not Available
Coma17.02.09.001--Not Available
Convulsion neonatal17.12.03.017; 18.04.04.003--Not Available
Death08.04.01.001--
Dermatitis23.03.04.002--Not Available
Disseminated intravascular coagulation24.01.01.010; 01.01.02.002--
Dyspnoea22.02.01.004; 02.01.03.002--
Electrocardiogram QT prolonged13.14.05.004--
Factor I deficiency03.15.01.001; 01.01.01.003--Not Available
Fluid overload14.05.06.001; 02.05.04.004--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Foetal distress syndrome18.03.02.003--Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypertonia17.05.02.001; 15.05.04.007--Not Available
Hyponatraemia14.05.04.002--
Hypotension24.06.03.002--
Immune system disorder10.02.01.001--Not Available
Jaundice neonatal01.06.04.006; 18.04.08.001; 09.01.01.008--Not Available
Muscle spasms15.05.03.004--
Myocardial ischaemia24.04.04.010; 02.02.02.008--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages